LEXARIA BIOSCIENCE CORP. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
LEXARIA BIOSCIENCE CORP. (LEXX) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$3.76 thousand for the 3-month period ending 2025-02-28, per its 10-Q filed 2025-04-14.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2025-04-14
- LEXARIA BIOSCIENCE CORP. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-02-28 was -$3.76K.
- LEXARIA BIOSCIENCE CORP. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2024-11-30 was -$2.93K.
- LEXARIA BIOSCIENCE CORP. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2024-02-29 was -$3.19K.
- LEXARIA BIOSCIENCE CORP. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2023-11-30 was -$5.71K.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month |
|---|---|---|
| 2025-02-28 | -$3.76K 10-Q · filed 2025-04-14 | -$6.69K derived: sum of 2 quarters · filed 2025-04-14 |
| 2024-11-30 | -$2.93K 10-Q · filed 2025-04-14 | |
| 2024-02-29 | -$3.19K 10-Q · filed 2025-04-14 | -$8.91K derived: sum of 2 quarters · filed 2025-04-14 |
| 2023-11-30 | -$5.71K 10-Q · filed 2025-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |